A synthetic molecule developed with support from the Blavatnik Biomedical Accelerator halts the growth of acute myeloid leukemia
Harvard materials scientists and chemists develop a rechargeable battery to power a home from rooftop solar panels
Twelve advanced research projects aimed at developing new therapies and diagnostics receive support from the Blavatnik Biomedical Accelerator
"The Accelerator bridges the gap between an academic research project and what's required for a startup to successfully raise capital."
OTD welcomes new HBS Blavatnik Fellows in Life Science Entrepreneurship